Apple has managed to pull in some extremely impressive numbers when it comes to its flagship mobile phone. While iPhone sales overall had begun to decline over the last quarter, that didn’t stop the company from selling its one billionth iPhone last week.
Apple’s CEO announced the milestone today during a special employee meeting in Cupertino this morning. Tim Cook, Apple CEO, thanked employees for “helping change the world every day,” noting that Apple has “always set out to make the best products that make a difference.”
The billionth iPhone was sold about two years after Apple sold its 500 millionth iPhone. That’s a lot of units, and with the impending launch of additional phones to its line, it’s likely to sell a whole lot more in the future.
Engadget RSS Feed
Although Apple’s ResearchKit is almost two years old, the platform has mainly been reserved for clinical studies hosted by universities and medical researchers. Hundreds of thousands of people are already contributing data for studies focusing on asthma, diabetes, breast cancer, autism, epilepsy and melanoma, but now drugmakers are getting in on the act. Almost a year after it said it was readying studies using Apple’s health data-collecting tool, GlaxoSmithKline (GSK) has confirmed the launch of a new research app to help monitor patients with rheumatoid arthritis.
GSK’s Patient Rheumatoid Arthritis Data from the Real World (PARADE) study is the first of its kind and is the first time a major pharmaceutical (or big pharma) company has embarked on such a project. PARADE is designed to look at the impact of rheumatoid arthritis on a patient’s life, by using iPhone sensors to collect information on joint pain, fatigue and overall mood. GSK will track the activity and “quality of life measures” for 300 patients over a three-month period.
Although GSK uses over 40 different technologies to collect health data, ResearchKit allows doctors, scientists and researchers to collect data more regularly and accurately from patients via their iPhone. It’s not testing a new treatment yet, but the company intends to use the data it collects to “develop medicines more effectively.”
Engadget RSS Feed
How do you catch up with the biggest music streaming service? Well, not approving app updates is one tactic, and Spotify says Apple is doing just that. The streaming service sent a letter to Apple’s legal counsel this week claiming that the company is rejecting an update to Spotify’s iOS app and it’s “causing grave harm” to users by doing so. The letter explains that Apple won’t approve the new version because Spotify doesn’t use the company’s billing method for in-app purchases and subscription services. Apple announced an changes to app subscriptions in iTunes just before this month’s WWDC.
Like other apps, Spotify had been getting customers to foot the bill for Apple’s App Store billing fees by charging an extra $ 3 a month. It recently launched a promotion for the second time that gave new users three months of service for a dollar, if they signed up on the web. As you can imagine, that didn’t make Apple too happy, and the company reportedly threatened to pull the app entirely unless Spotify stopped pushing the deal for iPhone owners. It complied with the request, but it also nixed the iTunes billing option in the iOS version which lead to the current dispute.
Sure, Spotify users can still sign up through its website to avoid paying the extra money every month. However, charging extra to pay through iTunes puts the streaming service at a disadvantage when it comes to competing with Apple Music. Spotify still has double the paying customers as Apple, but with exclusives and things like Beats1, the iPhone maker continues to gain ground. We’ve reached out to both Apple and Spotify on the matter and we’ll update this post when and if we hear back.
Engadget RSS Feed